Physician profile
John Calvin Sharp
NPI 1780673830
$10,695.21
in general payments reported to CMS, 2019-2025
38 companies · $1,930 in 2025
The $1,930 reported for 2025 was more than what 83% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,400 · 2020: $721 · 2021: $2,466 · 2022: $941 · 2023: $1,378 · 2024: $1,858 · 2025: $1,930.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,166.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,741.99 | 2021-2025 | Micra, Cobalt Dr Mri Surescan, Mycarelink |
| Boston Scientific Corporation | $2,165.53 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx, Watchman Access System |
| Novartis Pharmaceuticals Corporation | $940.51 | 2019-2025 | |
| Abbott Laboratories | $846.74 | 2019-2025 | Jot Dx, Gallant, Optis |
| E.R. Squibb & Sons, L.L.C. | $758.02 | 2019-2025 | Camzyos, Eliquis |
| Medtronic Vascular, INC. | $503.53 | 2019-2020 | |
| Amgen INC. | $331.58 | 2019-2025 | Repatha, Repatha |
| Atricure, INC. | $282.66 | 2022-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Biotronik INC. | $215.96 | 2019-2025 | Acticor 7 Vr-T Dx |
| Janssen Pharmaceuticals, INC | $199.48 | 2019-2023 | Xarelto |
| Cardiva Medical, INC. | $148.92 | 2021-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $147.92 | 2019-2025 | Lifevest |
| Edwards Lifesciences Corporation | $132.89 | 2025 | Sapien 3 Ultra Resilia |
| Actelion Pharmaceuticals US, INC. | $130.28 | 2024-2025 | Opsumit, Opsynvi, Uptravi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $123.06 | 2019-2023 | Jardiance |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $121.34 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $107.86 | 2019-2024 | Farxiga |
| Philips North America LLC | $95.38 | 2025 | Ambulatory Monitoring & Diagnostics Undivided, Ecc Solutions |
| Merck Sharp & Dohme LLC | $93.43 | 2023-2025 | Verquvo |
| Chiesi USA, INC. | $82.68 | 2021 | |
| Cvrx, INC. | $61.49 | 2021-2024 | Barostim Neo System |
| Irhythm Technologies, INC. | $57.25 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Shockwave Medical, INC | $51.06 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $40.17 | 2025 | |
| Astellas Pharma US INC | $36.07 | 2019 | |
| Biosense Webster, INC. | $33.32 | 2024 | Nuvision Ice Catheter |
| Regeneron Healthcare Solutions, INC. | $25.16 | 2019 | |
| Lundbeck LLC | $24.01 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $23.34 | 2020-2021 | |
| Alnylam Pharmaceuticals INC. | $21.27 | 2025 | Amvuttra |
| Scpharmaceuticals INC. | $21.27 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.96 | 2025 | |
| Arbor Pharmaceuticals, INC. | $20.09 | 2019 | |
| Medicure Pharma INC. | $19.66 | 2021 | |
| Vital Connect, INC | $19.39 | 2023 | Vitalpatch Rtm |
| Sanofi-Aventis U.S. LLC | $19.37 | 2019 | |
| Novo Nordisk INC | $18.18 | 2025 | Wegovy |
| Convatec INC. | $13.39 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Sharp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.